Western Pacific Wealth Management, LP Corvus Pharmaceuticals, Inc. Transaction History
Western Pacific Wealth Management, LP
- $105 Million
- Q1 2025
A detailed history of Western Pacific Wealth Management, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 2,000 shares of CRVS stock, worth $7,900. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$7,900
Previous $10,000
40.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CRVS
# of Institutions
105Shares Held
36.7MCall Options Held
1.37MPut Options Held
338K-
Orbimed Advisors LLC San Diego, CA6.94MShares$27.4 Million0.69% of portfolio
-
Samlyn Capital, LLC New York, NY4.07MShares$16.1 Million0.21% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$12.9 Million10.31% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.79MShares$11 Million0.02% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$10.6 Million0.14% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $184M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...